Zum Hauptinhalt springen


Zuletzt revidiert:
Zuletzt revidiert von:

  1. Gesellschaft für Thrombose- und Hämostaseforschung. Thrombozytopathien, Therapie. AWMF-Leitlinie Nr. 086-004, Stand 2014. www.awmf.org  
  2. Sullivan MT and Wallace EL. Blood collection and transfusion in the United States in 1999. Transfusion 2005; 45: 141-8. PubMed  
  3. Wandt H, Schäfer-Eckart K, Greinacher A. Thrombozytentransfusion bei hämatologischen und onkologischen Patienten sowie bei Operationen. Dtsch Arztebl Int 2014; 111: 809–15. DOI: 10.3238/arztebl.2014.0809 www.aerzteblatt.de  
  4. Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007; 370: 427-38. PubMed  
  5. Freireich EJ. Supportive care for patients with blood disorders. Br J Haematol 2000; 111: 68-77. PubMed  
  6. Sweeney J, Kouttab N, Holme S, Kurtis J, Cheves T and Nelson E. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion 2006; 46: 835-40. PubMed  
  7. Fournel JJ, Zingsem J, Riggert J, et al. A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion 1997; 37: 487-92. PubMed  
  8. Burgstaler EA, Pineda AA, Potter BM and Brown R. Plateletapheresis with a next generation blood cell separator. J Clin Apher 1997; 12: 55-62. PubMed  
  9. Strauss RG. Pretransfusion trigger, platelet counts and dose for prophylactic platelet transfusions. Curr Opin Hematol 2005; 12: 499-502. PubMed  
  10. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122: 10-23. PubMed  
  11. Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A, Heddle N. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD004269. DOI: 10.1002/14651858.CD004269.pub3. DOI  
  12. Hiippala S. Replacement of massive blood loss. Vox Sang 1998; 74 (suppl 2): 399-407.
  13. Bundesärztekammer. Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten, 4. akt. Auflage, Berlin 2014. www.bundesaerztekammer.de  
  14. Stanworth SJ, Hyde C, Brunskill S and Murphy MF. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Br J Haematol 2005; 131: 588-95. PubMed  
  15. Strauss RG. Low-dose prophylactic platelet transfusions: time for further study, but too early for routine clinical practice. Transfusion 2004; 44: 1680-2. PubMed  
  16. Heddle NM, Cook RJ, Sigouin C, Slichter SJ, Murphy M and Rebulla P. A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion 2006; 46: 903-11. PubMed  
  17. Legler TJ, Fischer I, Dittmann J, et al. Frequency and causes of refractoriness in multiply transfused patients. Ann Hematol 1997; 74: 185-9. PubMed  
  18. Leucocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337: 1861-9. New England Journal of Medicine  
  19. Rebulla P, Morelati F, Revelli N, et al. Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products. Br J Haematol 2004; 125: 83-9. PubMed  
  20. Brecher ME and Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18: 195-204. PubMed  
  21. Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997; 37: 423-35. PubMed  
  22. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force Transfus Med 1996; 6: 261-71. PubMed  
  23. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005; 33: 721-6. PubMed  
  24. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J and Blajchman MA. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005; 19: 2-31. PubMed  
  25. Silliman CC and McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev 2006; 20: 139-59. PubMed  
  26. Vassallo RR. Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products. Immunohematol 2004; 20: 226-33. PubMed  
  27. de la Rubia J, Plume G, Arriaga F, Carpio N, Sanz MA and Marty ML. Platelet transfusion and thrombotic thrombocytopenic purpura. Transfusion 2002; 42: 1384-5. PubMed  
  • Birgit Wengenmayer, Dr.med., Fachärztin für Allgemeinmedizin, Freiburg/Br.
  • Aurora Espinosa, overlege, Avd. for immunologi og transfusjonsmedisin, St. Olavs Hospital, Trondheim
  • Ewa Lassén, överläkare och medicinsk chef, Klinisk Immunologi och Transfusionsmedicin, Laboratoriemedicin, Norrlands universitetssjukhus, Umeå (Medibas)